FlandersBio on Twitter

Follow us on Twitter

Archive for September 2011 - News

Archive for September 2011 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

First Patients Enrolled in the PNB01 Phase III clinical development program in Major Depression


PharmaNeuroBoost (PNB), a globally operating CNS Specialty Biopharmaceutical Company, reported today that it enrolled in the USA the first patients in its Phase III study with PNB01 in Major Depressive Disorder (MDD). The primary objective of this pivotal study is to show a superior rate of Early and Sustained Responders (ESR) over standard of care citalopram and by this addressing an unmet medical need in the treatment of MDD, a devastating disorder. read more

De strategische alliantie tussen Roche en reMYND is genomineerd voor een Scrip Award


De strategische alliantie tussen Roche en reMYND om innovatieve behandelingen te ontwikkelen in de strijd tegen Parkinson en Alzheimer is genomineerd voor de Scrip Award “Best Partnership Alliance”. De ceremonie met de aankondiging van de winnaars en de uitreiking van de awards vindt plaats op 3 november in Londen. read more

Aeschylus provides final push for applied research


The Aeschylus philanthropy platform, recently established by K.U.Leuven, seeks funding for promising research projects in applied sciences that are in the final phase of development, just on the verge of commercialisation via spin-off or licensing. The platform supports research projects that have exhausted all other available funding sources, but which are just shy of securing venture capital. Aeschylus empowers private contributors to give these projects the final, crucial push they need to allow socially effective, breakthrough technologies to reach their target groups faster. read more

MDxHealth Confirms Progress on Companion Diagnostics Partnering


MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, confirmed today that it continues to make progress on partnering of its technology and companion diagnostics tests with pharmaceutical companies. read more

QUINVITA and Omnia Fertilizer sign collaboration agreement


Omnia Fertilizer, a division of Omnia Group (Pty) Ltd and the industrial crop technology company, QUINVITA, announced today that they have entered into a joint Jatropha development programme agreement. Per the agreement, Omnia Fertilizer becomes a member of the QUINVITA agronomy knowledge platform and is entitled to access any information and research regarding Jatropha curcas. Both companies agreed to commence collaborative research on the effect of specific fertilizer applications on Jatropha. read more

14 miljoen extra innovatiesubsidies voor het IWT


Het IWT, het agentschap voor Innovatie door Wetenschap en Technologie, is bijzonder verheugd over de beslissing van de Vlaamse Regering van vandaag. Op initiatief van Vlaams minister van Innovatie Ingrid Lieten krijgt het IWT voor 2012 14 miljoen euro extra middelen om innovatie te ondersteunen. Hiermee verhoogt de investering van de Vlaamse Regering in het IWT voor 2012 tot 324 miljoen euro. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top